SCHEMBL7187470

SCHEMBL7187470

CCOc1cccc(OCC)c1C=CC(=O)c1ccc(N)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ABCG2 Q9UNQ0 3/20 0.60
MAPT P10636 3/20 0.55
LMNA P02545 1/20 0.55
ATM Q13315 1/20 0.55
SMN1; SMN2 Q16637 1/20 0.55
MAOB P27338 5/20 0.50
CYP1B1 Q16678 2/20 0.50
MAOA P21397 1/20 0.50
CA1 P00915 2/20 0.48
CA2 P00918 2/20 0.48
KRAS P01116 1/20 0.48
NPC1 O15118 2/20 0.47
RAB9A P51151 2/20 0.47
KMT2A Q03164 1/20 0.47
CTSL P07711 1/20 0.46
CTSB P07858 1/20 0.46
BCHE P06276 1/20 0.46
CYP1A1 P04798 1/20 0.45
CYP1A2 P05177 1/20 0.45
CYP2D6 P10635 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7187466 1.00 ABCG2 (0.60) ABCG2MAPTLMNAATMSMN1; SMN2
SCHEMBL7184853 0.89 ABCG2 (0.57) ABCG2MAPTLMNAATMSMN1; SMN2
SCHEMBL7184728 0.88 ABCG2 (0.56) ABCG2MAPTLMNAATMSMN1; SMN2
SCHEMBL7184176 0.87 ABCG2 (0.61) ABCG2MAPTLMNAATMSMN1; SMN2
SCHEMBL7184186 0.87 ABCG2 (0.61) ABCG2MAPTLMNAATMSMN1; SMN2
SCHEMBL7101222 0.85 MAPT (0.76) MAPTLMNAATMSMN1; SMN2MAOB
SCHEMBL7177657 0.84 CYP1B1 (0.47) ABCG2MAPTLMNAATMSMN1; SMN2
SCHEMBL7177660 0.84 CYP1B1 (0.47) ABCG2MAPTLMNAATMSMN1; SMN2
SCHEMBL8471270 0.84 MAPT (0.44) ABCG2MAPTLMNAATMSMN1; SMN2
SCHEMBL7192430 0.84 ABCG2 (0.85) ABCG2MAPTLMNAMAOBCYP1B1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6603046-B1 The invention is drawn to novel bis-aromatic a, beta -unsaturated ketones. The compounds are useful in the treatment and prophylaxis of diseases caused by parasites or bacteria. LICA PHARMACEUTICALS A/S (DK) 2003-08-05 US disclosed
EP-0634927-B1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA LICA PHARMACEUTICALS AS (DK) 2001-07-04 EP disclosed
US-5985935-A PARASITICIDES OR BACTERICIDES STATENS SERUMINSTITUT (DK) 1999-11-16 US disclosed
EP-0634927-A1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA STATENS SERUMINSTITUT (DK) 1995-01-25 EP disclosed
WO-1993017671-A1 TREATMENT AND PROPHYLAXIS OF DISEASES CAUSED BY PARASITES, OR BACTERIA STATENS SERUMINSTITUT (DK) 1993-09-16 WO disclosed